HVAD risks: What you need to know

After a popular medical device for heart failure is taken off the market, a cardiac surgeon explains why most people won’t have theirs removed.

11:38 AM

Author | Jane Racey Gleeson

surgeons doing procedure close up
File photo: Cardiac surgeons Francis Pagani, M.D., and Jonathan Haft, M.D., in the operating room. Credit: Leisa Thompson Photography

First, "Don't panic."

This is the advice of University of Michigan Health cardiac surgeon Francis Pagani, M.D., after medical device maker Medtronic announced an abrupt stop to new implantations of its Heartware Ventricular Assist Device, also commonly known as an HVAD. No one else will be given the device, but 4,000 people across the country already have one in their chest. People with heart failure have ventricular assist devices implanted to help pump blood through the body.  

The problem reported with Medtronic's Heartware is an increased risk of neurological events, such as stroke, and potential delays restarting or failure to restart altogether.

Although the concerns are important, Pagani says people whose devices are working properly will likely be able to continue using them. After all, switching it out for another VAD would mean another big heart surgery.

"There is no benefit to exchanging to the HeartMate 3 (an alternative commercial left ventricular assist device) if the HVAD device is functioning normally," said Pagani, who sees patients at the Frankel Cardiovascular Center. "The data strongly suggests that those patients remain on the device."

MORE FROM MICHIGAN: Sign up for our weekly newsletter

(Pagani recently moderated a webinar about this topic with the Society of Thoracic Surgeons, as seen in the video above.)

University of Michigan Health patients implanted with the HVAD have been sent information about the device, including a request for them to contact their health care provider with any immediate concerns.

"We recommend that patients continue with their regularly scheduled follow up appointments with their heart failure cardiologists and the U-M Health VAD Team care providers," Pagani said.

In June, Medtronic issued an Urgent Medical Device Communication Notification to inform health care providers that the company had decided to stop selling and distributing the HVAD system because of the safety concerns. People who need a VAD device moving forward will be offered a different one instead.

What if I already have one of these Medtronic HVAD devices that's been taken off of the shelves?

For the approximately 4,000 patients who currently have a Medtronic HVAD nationwide, the company shared these recommendations regarding the device:

  • Continue to follow up regularly with your surgeon, physician or VAD coordinator and follow your health care provider's advice and directions. 

  • Medtronic is developing a support program that will include financial assistance for eligible patients. 

  • Medtronic will provide ongoing product support for the HVAD System and will ensure continued availability of batteries and a controller.

  • Never disconnect your HVAD pump from two power sources at the same time and always have a back-up controller and fully charged spare batteries available.

If you are a U-M patient and would like to speak with a member of the Michigan Medicine staff about the Medtronic device and this issue, please call 734-647-7321 and select option 2.

Like Podcasts? Add the Michigan Medicine News Break on iTunes, Google Podcasts or anywhere you listen to podcasts


More Articles About: Health Management Diagnosis of Heart Condition Interventional cardiology Cardiovascular: Diseases & Conditions Cardiovascular: Preventive Cardiology LVADs, VADs and Other Assist Devices Cardiovascular: Diagnostics & Procedures
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories watch on hand
Health Lab
Tailored text messages not enough to improve mobility after heart issues
A Michigan Medicine report shows that adding a mobile health application to such devices yields mixed results. Tailored text messages to encourage high-risk people to move more may improve some short-term outcomes but doesn’t always improve physical activity levels for everyone.
man smiling sitting
Health Lab
A unique collaboration helps one patient better manage aortic disease
MI-AORTA is a donor-funded initiative that facilitates collaboration within the Frankel Cardiovascular Center, U-M Health and referring provider networks, creating value for the patients, families, and communities they serve and allows them to continue to pioneer advanced therapies for aortic diseases.
man standing
Health Lab
Beating the odds against chronic total occlusion
Learn about the latest advances in treatment for chronic total occlusion, a life-threatening condition that deprives the heart of oxygen. A team of cardiovascular surgeons perform advanced, minimally invasive surgery to help David Schneider get his life back on track.
lungs
Health Lab
Pulmonary embolism deaths, disparities high despite advancements in care
Despite these innovations, a Michigan Medicine study finds that the death rate for pulmonary embolism remains high and unchanged in recent years – more often killing men, Black patients and those from rural areas. The results are published in the Annals of the American Thoracic Society.
hospital staff emergency room patient rush
Health Lab
Nearly three-quarters of stroke patients requiring higher level of care wait over two hours for transfer
More than 70% of people experiencing a stroke who require a transfer wait longer than two hours to be transferred from the initial emergency department to hospitals with higher levels of care to receive time-sensitive care, a study finds.
cartoon of hospital workers and patient
Health Lab
Children who suffer cardiac arrest more likely to survive at ECMO capable hospitals
Children who experience cardiac arrest are one and a half times more likely to survive at a hospital capable of providing the life support system called ECMO, research suggests. But the reason behind better outcomes may have less to do with being saved by the heart and lung support machine itself and more to do with the care team structure at hospitals capable of ECM0, suggests the findings in Resuscitation.